Deoxynucleotide Triphosphates (dNTPs) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, China, Japan - Size and Forecast 2024-2028

Deoxynucleotide Triphosphates (dNTPS) Market 2024-2028 

The Deoxynucleotide Triphosphates (dNTPS) Market size is estimated to grow at a CAGR of 7.26% between 2023 and 2028. The market size is forecast to increase by USD 77.45 million. The growth of the market depends on several factors such as the rising prominence of PCR in the biomedical sector, expanding applications of DNA sequencing, and increasing DNA synthesis procedures. 

The report includes a comprehensive outlook on the Deoxynucleotide Triphosphates dNTPS Market, offering forecasts for the industry segmented by product type which comprises liquid dNTPS, and solid dNTPS. Additionally, it categorizes application into research institutions, pharmaceutical and covers Geography regions, including North America, Europe, Asia, and Rest of World (ROW). The report provides market size, historical data spanning from 2018 - 2022, and future projections, all presented in terms of value in USD million for each of the mentioned segments.

What will be the size of the Deoxynucleotide Triphosphates dNTPS Market During the Forecast Period?

For More Highlights About this Report, Download Free Sample in a Minute 

Deoxynucleotide Triphosphates dNTPS Market: Key Drivers, Trends and Challenges

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Deoxynucleotide Triphosphates dNTPS Market Driver 

Expanding applications of DNA sequencing are notably driving the market growth. Deoxynucleotide triphosphates dNTPS are used in labs for a myriad of applications, including DNA sequencing. DNA sequencing is gaining prominence in many areas, including biology and other sciences, such as forensics, anthropology, and medicine, due to its increasing number of applications. DNA sequencing has a wide range of applications that range from the determination of the entire genome of any organism to the sequencing of individual genes. In molecular biology, DNA sequencing is used to identify the genetic mutations associated with several diseases as well as potential therapeutic targets for effective treatment. DNA sequencing is also used to study evolutionary history as genetic information is transferred from one generation to the next.

Moreover, DNA sequencing is considered a key analytical tool in forensics. Sequencing is usually performed along with DNA profiling procedures for forensic identification as well as paternity testing. Some major investigative samples include hair follicles, saliva, and fingerprints, all of which present unique and individualized DNA patterns that separate each living organism from others. Therefore, the expanding applications of DNA sequencing are likely to drive the growth of the market during the forecast period.

Key Deoxynucleotide Triphosphates dNTPS Market Trends

The rising use of oligonucleotides as therapeutic and diagnostic tools is an emerging trend shaping the market growth. 

The biomedical sector is witnessing significant use of oligonucleotides, which include short, single- or double-stranded DNA or RNA molecules in vitro diagnosis and therapeutics owing to their high specificity and excellent sensitivity. Genetic diagnosis of targets, peptides, small molecules, and proteins are some applications where oligonucleotide is considerably used.  Promising opportunities in antisense oligonucleotide technology have surged the demand for oligonucleotide synthesis for therapeutic manufacturing.

Additionally, the deoxynucleotide triphosphates (dNTPs) market is observing a rising demand from the pharmaceutical and biotechnology sectors owing to the increasing commercial approval of oligonucleotide therapies by authorities such as the US FDA and EMA. Genetic testing, a crucial application area for dNTPs, is also contributing to market growth. The expanding adoption of genetic testing for diagnostics, personalized medicine, and research purposes necessitates reliable and high-quality dNTPs. This trend underscores the critical role of dNTPs in supporting advancements in genetic testing technologies. As regulatory approvals for oligonucleotide therapies continue to grow, the demand for dNTPs is expected to further escalate, driving the global market for deoxynucleotide triphosphates during the forecast period.

Major Deoxynucleotide Triphosphates dNTPS Market Challenge

Stringent regulations related to dNTPS are a significant challenge hindering market growth.  Variation in regulatory standards and compliances globally is among the primary challenges faced by vendors in the global deoxynucleotide triphosphates (dNTPS) market. Vendors offer deoxynucleotide triphosphates dNTPS that are used in highly regulated applications such as research and drug discovery, which expose their products to strict compliance requirements in terms of accuracy, quality, safety, and performance. Lack of specificity and variation in regulatory standards can create confusion during product compliance among deoxynucleotide triphosphates (dNTPS) market vendors. Failure in compliance can restrict the commercial entry of new products or result in the recall or discontinuation of an already commercialized product. This can adversely impact vendors' businesses.

Moreover, to get approval in such a complex regulatory structure, deoxynucleotide triphosphates market vendors largely rely on third parties that offer consulting services for regulatory compliance. This increases their reliance on third parties and creates a demand for additional investments, resulting in a financial burden. Thus, stringent regulations in the market will negatively impact the market in focus during the forecast period.

Deoxynucleotide Triphosphates dNTPS Market Customer Landscape

The market research report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Deoxynucleotide Triphosphates dNTPS Market Customer Landscape

Who are the Major Deoxynucleotide Triphosphates dNTPS Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

biotechrabbit GmbH - The company offers deoxynucleotide triphosphates (dNTPS) namely biotechrabbit deoxynucleotide triphosphates.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

• BR Biochem Life Sciences Pvt. Ltd.
• Central Glass Co. Ltd.
• Creative Biogene
• Geneaid Biotech Ltd.
• Hefei Huana Biomedical Technology Co. Ltd.
• Hzymes Biotechnology Co. Ltd.
• Jena Bioscience GmbH
• Larova GmbH
• Maravai LifeSciences Holdings Inc.
• MCLAB
• Merck KGaA
• Meridian Bioscience Inc.
• Promega Corp.
• SBS Genetech Co. Ltd.
• Thermo Fisher Scientific Inc.
• Wizbiosolutions Inc.
• WUHU HUAREN SCIENCE AND TECHNOLOGY CO. LTD.
• New England Biolabs Inc.
• Takara Bio Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

What are the Largest-Growing Segments in the Deoxynucleotide Triphosphates dNTPS Market?

The liquid dNTPS are estimated to witness significant growth during the forecast period. Multiple concentrations of liquid dNTPS mix and solutions are suitable for molecular biology applications. The increasing incidence of infectious diseases and genetic disorders is leading researchers and scientists to opt for molecular biology solutions, including dNTPS, for the diagnosis and treatment of various infections. Researchers are increasingly focusing on molecular biology due to its high impact on diagnosing and treating diseases using gene therapy and recombinant vaccines. 

Get a glance at the market contribution of various segments Download the PDF Sample

The liquid dNTPS were the largest and were valued at USD 144.05 million in 2018. In recent years, the increasing prevalence of chronic diseases, such as cancer, among individuals is fueling the demand for early diagnosis of diseases to offer better patient care. Also, the incidence of infections caused by pathogens such as viruses and parasites is increasing, resulting in infections such as hepatitis and chronic viral infections. Hence, an increase in the prevalence of chronic and infectious diseases, coupled with the rising demand for the treatment of infectious diseases and genetic disorders using recombinant DNA technology, is expected to propel the growth of the segment and global deoxynucleotide triphosphates (dNTPS) market during the forecast period.

Which are the Key Regions for the Deoxynucleotide Triphosphates dNTPS Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The high growth of the deoxynucleotide triphosphates market in North America is majorly attributed to the presence of many testing laboratories, research facilities, sub-contract laboratories, and pharmaceutical companies in this region. Countries such as the US and Canada are propelling the demand for dNTPS in this region owing to the increasing number of biomolecule research. North America boasts the largest number of cancer research institutions globally, utilizing dNTPs solutions across various applications, including the analysis of multiple parameters in cancer patients. These institutions rely on customized products for cancer-related research, presenting lucrative opportunities for vendors to collaborate on developing innovative solutions and exploring new application areas such as RNAi drug delivery. The integration of dNTPs in RNAi drug delivery systems underscores their pivotal role in advancing therapeutic strategies against cancer and other diseases. By fostering partnerships and advancing product development in emerging fields like RNAi drug delivery, vendors can enhance market growth and expand product penetration into novel applications.

In addition, countries such as the US and Canada are witnessing a rise in investments in genomics research, which includes the application of deoxynucleotide triphosphates dNTPS for cloning and other applications. In September 2022, the Centers for Disease Control and Prevention (CDC) announced a funding of USD 90 to support the Pathogen Genomics Centers of Excellence (PGCoE) network. Thus, a rise in the number of genomics research activities is expected to drive the growth of the deoxynucleotide triphosphates (dNTPS) market in North America during the forecast period.

The COVID-19 outbreak in 2020 positively affected the regional market by directly influencing the production of and demand for dNTPS in PCR. Moreover, in 2021, the mass vaccination drives and ease of lockdown measures led to normalcy in the region, which led to the resumption of normal business in the region. Furthermore, the rising cases of chronic diseases such as cancer in the region are expected to fuel the growth of the deoxynucleotide triphosphates (dNTPS) market in the region during the forecast period.

Segment Overview

The deoxynucleotide triphosphates dNTPS market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

• Product Type Outlook 
  • Liquid dNTPS
  • Solid dNTPS

• Application Outlook 
  • Research institutions
  • Pharmaceutical

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • South America
    • Chile 
    • Brazil
    • Argentina 
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • APAC
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

Download PDF Sample

What are the Key Data Covered in this Deoxynucleotide Triphosphates dNTPS Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the market between 2024 and 2028
• Precise estimation of the market  size and its contribution to the market in focus to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch